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Abstract Nitric oxide (NO) is a diffusible messenger involved in several patho-physiological processes including immune-mediated cytotoxicity and 
neural cell killing. NO or the products of its redox chemistry can cause DNA damage and activate subsequent lethal reactions including energy 
depletion and cell necrosis. However, regardless of whether it is endogenously produced in response to cytokines, or generated by chemical breakdown 
of donor molecules, NO can also induce apoptosis in different systems. Here, we report that NO generation in response to a cytokine induced 
NO-synthase or by NO donors stimulates the expression of the tumor suppressor gene, ~53, in RAW 264.7 macrophages or pancreatic RINm5F 
cells prior to apoptosis. NO-synthase inhibitors such as No-monomethyl+arginine prevent he inducible NO generation as well as p53 expression 
and apoptosis. Since ~53 expression is linked to apoptosis in some cells exposed to DNA damaging agents, we suggest hat NO-induced apoptosis 
in these cell systems is the consequence of DNA damage and subsequent expression of this tumor suppressor gene. 
Key words: Nitric oxide; ~53; Apoptosis; DNA fragmentation 
1. Intraductioll 
Nitric oxide (NO) is a messenger molecule involved in several 
processes including relaxation of smooth muscle, neurotrans- 
mission, and tumor cell as well as bacteria killing [l-3]. How- 
ever, induction of a high output system for NO in response to 
cytokines or a massive production of NO following accumula- 
tion of the excitatory neurotransmitter glutamate [4,5] can re- 
sult in cell killing. Neurons [6], pancreatic B-cells [7] or macro- 
phages [8,9] seem to be particularly sensitive to NO toxicity. 
While in some systems NO can react with other radicals and 
effectively cause cell death by necrosis, in others the progressive 
intra- or extracellular generation of NO has been suggested to 
cause apoptosis [8,10,11]. Mechanisms proposed for NO toxic- 
ity include its interaction with protein thiol groups [3,12] or 
iron-sulfur proteins [13], or by direct DNA damage [14]. The 
latter, regardless of whether it is induced by radiation or by 
drugs such as etoposide, can result in apoptosis [15,161. Expres- 
sion of wild-type ~53, a tumor suppressor gene, seems to be 
closely linked to apoptosis caused by most of the DNA-damag- 
ing agents [15,16]. The wild-type nuclear phosphoprotein ~53, 
originally characterized as a tumor suppressor protein [17], acts 
as a checkpoint control in the cell cycle, permitting the repair 
of damaged DNA. The block in GJS transition which results 
from ~53 activation has been suggested to cause apoptosis in 
the case of severe DNA damage [18,19]. More recently, it has 
become apparent that the ~53 gene product can take part di- 
rectly in the apoptotic process [20]. 
2. Materials and methods 
2.1. Materials 
The mouse macrophage-like cell line RAW 264.7 was provided by 
Prof. A. Wendel, Faculty of Biology, University of Konstanz, 
Germany. LPS (Escherichia coli serotype 0127:B8), NMMA, protein 
A-Sepharose, and SNP were purchased from Sigma, Deisenhofen, 
*Corresponding author. Fax: (49) (7531) 883 099. 
Abbreviations: IFN-y, recombinant murine interferon-y; LPS, lipopol- 
ysaccharide; NMMA, No-monomethyl+arginine; NO, nitric oxide. 
Germany. Recombinant murine interferon-r was from Boehringer- 
Mannheim, Mannheim, Germany, while ‘zsI-labeled protein A (10 mCi/ 
mg) was bought from DuPont-New England Nuclear, Dreieich, Ger- 
many. RPM1 1640 supplemented with 0.532 g/l N-acetyl-L-alauyi-L- 
glutamine was ordered from Biochrom, Berlin, Germany. Cell culture 
supplements, fetal calf serum and agarose were from Gibco, Berlin, 
Germany. All other chemicals were of the highest grade of purity 
commercially available. 
2.2. GSNO synthesti 
GSNO (S-nitroso derivative of glutathione) was freshly synthesized 
prior to use as described previously [21]. Briefly, glutathione was dis- 
solved in 0.625 N HCl at 0°C to a final concentration of 625 mM. An 
equimolar amount of NaN02 was added and the mixture was stirred 
at 0°C for 40 min. After the addition of 2.5 ~01s. of acetone, stirring 
was continued for another 20 min, followed by filtration of the precip- 
itate. GSNO was washed once with 80% acetone, two times with 100% 
acetone, and finally three times with diethylether, and then was dried 
under vacuum. GSNO was characterized by HPLC analysis and UV 
spectroscopy. 
2.3. Inununoprecipitation a d Western blotting 
For each assay 2 x 10’ cells were incubated in 10 cm Petri dishes with 
the appropiate substances for the times indicated, scraped off using a 
rubber noliceman and lvsed for 20 mitt in 700 ul lvsis buffer (50 mM 
Tris, 5 mM EDTA, 150 mM NaCl, 0.5% Nonidet46,l mM PI&F, pH 
8.0). Lysed cells were sonicated for 10 s using a Branson sonifler (duty 
cycle lOO%, output control 1). After centrifugation for 5 min at 
13,000 x g, non-specific adsorbants were removed from the resulting 
supernatant by an incubation with 40~150% (v/v) protein A-Sepharose 
for 10 min at 4”C, followed by centrifugation for 15 min at 13,~ooO x g. 
~53 was immunoprecipitated overnight at 4°C by adding 200 ~1 hybr- 
idoma supematant (clone PAb 122) and 50 ~1 50% protein A-Sepha- 
rose. Immunecomplexes were spun down at 13,000 x g for 60 s and 
washed 3 times with 500 ul SNNTE (5% sucrose. 1% Nonidet-40. 0.5 
M NaCI, 50 mM Tris, 5 ‘mM EDTA; pH 7.4) and another time with 
1 ml SNNTE. Finally, samples were resuspended in40~1 sample buffer 
(125 mM Tris. 2% SDS. 10% alvcerin. 1 mM DTT. 0.002% Bromonhe- 
no1 blue, pH 6.9) and boiled & 5 min. Proteins were resolved on 10% 
SDS-polyacrylamide gels, and blotted onto nitrocellulose sheets using 
the semi-dry blot system from Pharmacia (0.8 mA/cm’, 1.25 h; 25 mM 
Tris, 192 mM alvcine buffer system). The sheets were washed twice with 
TBS (140 mMNaC1, 50 mM Tris,~pH 7.2) containing 0.1% Tween-20 
before blocking unspecific binding with TBS, 2% BSA for 1 h at 2O“C. 
The ~53 antibody was added (hybridoma supematant against ~53; 
clone PAb122; 1: 6 in TBS, 0.2% BSA) and incubated overnight at 4’C. 
Nitrocellulose sheets were washed 5 times and unspecific binding was 
blocked as described. For detection, blots were incubated with [‘251]pro- 
tein A (2 ng/ml protein A, 1 &i in TBS, 0.06% Tween-20, 0.1% BSA) 
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for 2 h followed by quantitative determination of radioactivity using 
the phosphor image system (Molecular Dynamics) [22]. 
2.4. DNA agarose gel-electrophoresis 
For the preparation of DNA for agarose gelelectrophoresis, cells 
were harvested, lysed, and centrifuged as described above to separate 
DNA fragments from intact chromatin. Supematants were precipitated 
with 1 ml ice-cold ethanol and 50 J 5 M NaCl at -2O’C, centrifuged 
again at 13,000 x g for 15 min and each pellet was incubated in 500 ~1 
TE buffer sunnlemented with 100 tie/ml RNase A at 37’C for 30 mm. 
Samples were-extracted with an equal volume of phenol/chloroform/ 
isoamylalcohol (25: 24: 1) and once again with an equal volume of 
chloroform/isoamylalcohol (24 : 1). DNA was precipitated overnight 
with 1 ml ethanol and 50 pl 5 M NaCl at -20°C. DNA pellets were 
recovered by centrifugation (13,000 x g, 15 min), air dried, resuspended 
in 10 ~1 TE buffer, supplemented with 2 ~1 sample buffer (0.25% Bro- 
mophenol blue, 30% glyceric acid), and electrophoretically separated 
on a 1% agarose gel containing 1 @ml ethidium bromide for 2.5 h at 
100 V. Pictures were taken by UV transilhunination. 
2.5. Immunohistochemistry 
Rat pancreatic RINmSF cells were seeded at a density of 5 x 10’ 
cells/cm2 onto poly+lysine-coated glass cover slips and grown for 
4 days to a density of approximately 2x lo5 cells/cm*. After exposure 
to IL-lb or SNP, cells were fixed in methanol/water (80:20), rinsed in 
phosphate-bufferec saline with 0.1% Triton X-100 and incubated with 
10% goat serum followed by overnight incubation with anti-p53 mono- 
clonal antibody PAb421. Thereafter, cells were treated with FITC- 
conjugated anti-mouse IgG antibodies followed by staining with 20pM 
ethidium homodiier 1. Cells mounted on glass slides were examined 
in a Bio-Rad MRC 600 confocal microscope system, where the excita- 
tion was provided by a Krypton-Argon laser line at 488 mn. Fluorese- 
cence was collected in the green and red region for anti-p53-Ig com- 
plexes and ethidium homodimer, respectively. 
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2.6. Nitrite determination 
Nitrite, a stable NO oxidation product, was determined using the 
Griess reaction [23]. Cell-free culture supematants were collected (200 
pl), adjusted to 4°C mixed with 20 ~1 sulphanilamide (dissolved in 1.2 
M HCl) and 20 ul N-nanhthvlethvlenediamine dihvdrochloride. After 
5 min at room temperaiure ihe absorbance was measured at 560 nm 
with a reference wavelength at 690 nm. Nitrite concentrations were 
calculated using a NaNO, standard. 
3. Results and discussion 
We have recently studied the characteristics of NO-mediated 
cell death in the mouse macrophage cell line RAW 264.7 as well 
as in the rat pancreatic /I-cell line RINmSF. In both systems 
induction of the NO-synthase and concommitant NO genera- 
tion results in cell death by apoptosis [lO,ll]. RAW 264.7 mac- 
rophages, stimulated with lipopolysaccharide (LPS) and inter- 
feron-y (IFN-y) as agonists express high levels of the inducible 
form of the NO-synthase as determined by nitrite accumulation 
in the cell supernatant. Control cells produced virtually no 
nitrite over 24 h (C 0.1 mnol NO;/106 cells), while agonist addi- 
tion led to massive nitrite accumulation (9.4 + 2.5, 43.4 f 1.7, 
and 63.6 + 3.9 nmol N0;/106 cells after 6, 14, and 24 h, respec- 
tively; mean + S.D., n = 6). LPSIIFN-y-induced nitrite produc- 
tion was significantly repressed in the presence of the NO- 
synthase inhibitor @-monomethyl-L-arginine (NMMA), 
applied together with the agonists at a concentration of 1 mM 
(1.1 + 0.2, 7.2 f 0.9, and 16.3 + 4.2 nmol NOT/lo6 cells after 
6, 14, and 24 h, respectively; mean It S.D., n = 6). Probing for 
I3 
4- p53 
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Fig. 1. (A) Immunoprecipitation and Western blotting of ~53 from RAW 264.7 macrophages after endogenous NO-production. Cells (2 x 10’) were 
treated for the times indicated with 10 &ml LPS and 100 U/ml IFN-r (lane 2). 10 mu/ml LPS, 100 U/ml IFN-r and 1 mM No-monomethvl+arainine 
(NMMA) (lane 3) or uintreated as a’c&trol (lane 1). M indicates i4d-labeilkd molecular weight markers. The figure is representativeof 3 s&ar 
experiments. (B) DNA fragmentation in RAW 264.7 macrophages induced by endogenous NO production. 2 x 10’ cells were incubated as indicated 
in A. Cells were lysed and DNA fragments were separated from intact chromatin as described in section 2. The gel is typical of three independent 
experiments. 
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Fig. 2. (A) Time-dependent p53 up-regulation i  RAW 264.7 macroph- 
ages induced by S-nitrosoglutathione (GSNO). 2 x 10’ cells were incu- 
bated with 1 mM GSNO or vehicle (control) for the times indicated. 
Other details are as in Fig. 1A. M indicates “C-labelled molecular 
weight markers. The blot is typical of three similar experiments. 
(B)?hne-dependent DNA fragmentation in RAW 264.7 m&rophages 
induced bv GSNO. 8 x lo6 cells were incubated with 1 mM GSNO or 
vehicle (&trol) for the times indicated. DNA fragments eparated 
from intact chromatin were visualized byUV transillumination after 
agarose gel-electrophoresis. Results are representative of three similar 
assays. 
p53 levels in macrophage cell extracts employing immunopre- 
cipitation followed by Western blotting revealed hardly detect- 
able p53 protein levels under control conditions (Fig. IA). 
Addition of LPSIIFN-y caused a significant p53 accumulation 
within 14 h, which could be linked to NO production, as meas- 
ured by nitrite generation. To directly prove a role for NO 
during p53 accumulation, cells were incubated with NMMA, 
an NO-synthase inhibitor, prior to the exposure to NO-syn- 
thase-inducing agents (Fig. 1A). NO production as well as p53 
accumulation were inhibited. In LPSIIFN-y exposed macroph- 
ages, death occurred then by apoptosis as juged by morpholog- 
ical parameters, i.e. chromatin condensation and as investi- 
gated by the formation of apoptotic DNA-laddering [lo] (Fig. 
1B). 
To test the involvement of NO further, while at the same time 
excluding any interference of LPSIIFN-y on p53 accumulation, 
macrophages were exposed to S-nitrosoglutathione (GSNO). 
25 
The extracellularly applied NO donor decomposes non-enzy- 
matically to release NO’ or NO’ (nitrosonium ion). Addition 
of GSNO resulted in marked DNA fragmentation, appearing 
after 6 h (Fig. 2B). p53 accumulation under these conditions 
was rapid, starting already 1 h after GSNO application, reach- 
ing maximum levels after 4-5 h. In line with experiments de- 
scribed in Fig. 1, p53 expression clearly preceded DNA ladder 
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Fig. 3. Nitric oxide-induced p53 up-regulation in RINmSF cells. 
(A) Cells incubated with medium alone for 72 h, (B) cells exposed to 
recombinant human IL-IS (10 U/ml) for 72 h, (C)cells treated with 300 
/IM sodium nitroprusside (SNP) for 3 h. Images are representative of
at least 10 separate images collected from different fields in 3 individual 
experiments. Following IL-l/I treatment about 40% of the cells became 
positive to p53 staining between 48 and 72 h, consistent with our 
previous findings [l 11. About 30% of cells treated with SNP were pos- 
itive to p53 staining after 3 h. At 9 h 30-4096 of all cells had apoptotic 
bodies. 
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formation, irrespective of whether NO is endogenously gener- 
ated or exogenously applied. 
IL-l/J-induced NO generation in RINmSF cells causes the 
appearance of the typical apoptotic features, DNA fragmenta- 
tion, nuclear condensation and apoptotic body formation [ 111. 
Immunohistochemistry now reveals that IL-lp stimulates p53 
expression in this cell line (Fig. 3B). p53 positive immunostain- 
ing was especially visible in cells located in the center of the 
colonies, which were in the process of shrinking and forming 
apoptotic nuclei (Fig. 3B). In untreated cells p53 was visibly 
absent (Fig. 3A). To ascertain whether NO itself elicited p53 
accumulation, we administered the NO-generating compound 
sodium nitroprusside (SNP). The NO releaser caused increased 
p53 expression after 3 h (Fig. 3C) and subsequent apoptosis 
between 6 and 9 h (not shown). 
Our observations using RAW 264.7 macrophages and 
RINm5F cells demonstrate that p53 protein accumulates in 
response to nitric oxide. An active, cytokine-inducible NO- 
synthase mediates both apoptosis and p53 accumulation under 
these conditions. The potential of NO to induce p53 accumula- 
tion is evident in different cells, regardless of whether it is 
formed endogenously after NO-synthase induction or gener- 
ated by structurally different NO-releasing compounds. Thus, 
NO is directly responsible for the increased p53 expression. It 
is apparent hat NO can cause DNA damage [24,25], and recent 
work has indicated that NMDA- and NO-mediated neurotox- 
icity is associated with the activation of poly(ADP-ribose) syn- 
thase [26], a nuclear enzyme activated by DNA strand breaks, 
in the presence of NAIS. Following DNA damage, an in- 
creased emand for DNA repair is associated with p53 expres- 
sion. The latter may have the dual role of causing cell cycle 
arrest via downstream genes [27] and to stimulate DNA repair 
directly [28]. However, intranuclear p53 accumulation follow- 
ing DNA damage can also be part of the signalling leading to 
apoptosis either directly acting on the DNA [20] or again by 
causing cell cycle block [29]. In view of these considerations, 
our findings are consistent with a mechanism whereby NO- 
induced DNA damage results in p53 expression and apoptosis. 
Accumulation of p53.in response to NO, together with previous 
evidence that NO can cause growth arrest, cell necrosis and has 
antitumor properties [I], supports the notion that NO may 
signal different forms of cell death, i.e. necrosis vs. apoptosis. 
This may depend on the cell type and/or the steady-state con- 
centration of the NO redox species involved. 
NO-induced p53 expression, with its potential role in regulat- 
ing the cell cycle clock and initiating apoptosis, may have the 
dual role of signalling either growth arrest (supported by vari- 
ous reports that NO inhibits cell proliferation-in different sys- 
tems [30]) or death. Negative and positive modulators of apop- 
tosis may then determine the susceptibility of cells to the toxic 
insult. 
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